Board Member at Opexa Therapeutics, Inc.
Mr. Richman joined the Board of Directors of Pieris effective upon the closing of the Acquisition and has served on the supervisory board of Pieris Pharmaceuticals GmbH since October 2014. He is currently the President and Chief Executive Officer of NextCure, Inc. From 2008 through 2015 Mr. Richman was President and CEO of Amplimmune, Inc., a privately held biologics company focused on cancer and autoimmune diseases which was acquired by Astra Zeneca in 2013. From May 2007 through June 2008, he served as President and Chief Operating Officer of Amplimmune, Inc. Prior to such time, Mr. Richman has gained years of experience working in research ...
Source: Pieris Pharmaceuticals, Inc. on 04/11/2016
By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Michael S. Richman. More specifically, you'll be able to:
Search for over 360,000 executive profiles.
Example: Michael S. Richman
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.